Related Experiment Video
Updated: Mar 6, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Intestinal drug efflux: formulation and food effects
D Wagner1, H Spahn-Langguth, A Hanafy
1Department of Biopharmaceutics and Pharmaceutical Technology, School of Pharmacy, Johannes Gutenberg-University, Staudingerweg 5, 55099 Mainz, Germany.
Abstract:
The intestine, primarily regarded as an absorptive organ, is also prepared for the elimination of certain organic acids, bases and neutral compounds depending on their affinity to intestinal carrier systems. Several of the transport systems known to mediate efflux in the major clearing organs--liver and kidney--are also expressed in the intestine. Examples of secretory transporters in the intestine are P-glycoprotein, members of the multidrug resistance associated protein family, breast cancer resistance protein, organic cation transporters and members of the organic anion polypeptide family. In this communication, the P-glycoprotein mediated intestinal secretion of talinolol, a model compound showing metabolic stability, has been investigated in the jejunum, ileum and colon of rat intestine by single-pass perfusion. A model has been developed which demonstrates an increase in carrier-mediated secretion in the order jejunum
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability: Influencing Factors
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drug Absorption: Factors Affecting GI Absorption
Factors Influencing Drug Absorption: Drug Dissolution

